483 Nesher Pharmaceuticals (USA) Jan 2005

483 Nesher Pharmaceuticals (USA) Jan 2005

Gwyn Dickinson FDA, Patrick Wisor FDA$119.00 - Available Now

FDA investigators audited the Nesher Pharmaceuticals (USA) - Saint Louis, MO, United States facility and issued inspectional observations (via FDA 483) on 28 Jan 2005.

Product details

  • Category: Human Drugs
  • Inspection end: 28 Jan 2005
  • Location: Saint Louis, United States
  • FEI: 1937079
Add To Cart